ISPR
Ispire Technology Inc.
NASDAQ · Consumer Defensive · Tobacco · US
$1.33
−2.21%Year over year
Reported trailing growth
- Revenue
- -24.7%
- EBITDA
- —
- EBIT
- +13.9%
- EPS
- +14.8%
- Free cash flow
- -38.5%
- Operating cash flow
- -55.7%
Forward estimates
Based on analyst estimates
- Revenue
- -12.8%
- EBITDA
- +106.4%
- EPS
- +90.6%
Three-year CAGR
- Revenue
- -6.0%
- EBITDA
- +16.6%
- EBIT
- +13.9%
- Net income
- —
- EPS
- +15.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026